Biology Newsfeed

Europe's oncologists back biosimilar versions of cancer drugs

Reuters: Science - Posted: January 18th, 2017, 9:28am UTC

(Reuters) - Europe's leading association of oncologists has thrown its weight behind cheaper copycat versions of biotech cancer drugs that have lost patent protection, saying they are effective and affordable.div class="feedflare" a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=PgD3sPTJnak:nErkviFkACc:yIl2AUoC8zA"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?d=yIl2AUoC8zA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=PgD3sPTJnak:nErkviFkACc:F7zBnMyn0Lo"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=PgD3sPTJnak:nErkviFkACc:F7zBnMyn0Lo" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=PgD3sPTJnak:nErkviFkACc:V_sGLiPBpWU"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=PgD3sPTJnak:nErkviFkACc:V_sGLiPBpWU" border="0"/img/a /divimg src="http://feeds.feedburner.com/~r/reuters/scienceNews/~4/PgD3sPTJnak" height="1" width="1" alt=""/

Read more

Return to the Newsfeed